Session Type
Meeting
Search Results for Opioid use disorder
Abstract Number: 194
SHM Converge 2021
Background: Patients with Substance Use Disorder (SUD) are a nationwide concern. They have significant morbidity, mortality & for several reasons, such as comorbid psychiatric conditions, medication noncompliance, low income or poor access to healthcare services, have an increased risk of hospital readmissions. Processes aimed at reducing readmission rates in this population are important for improving […]
Abstract Number: 207
SHM Converge 2021
Background: Hospitalizations among patients with opioid use disorder (OUD) have skyrocketed in the past 10 years (1). These patients represent an ever-growing portion of the typical hospital medicine census and often have readmission rates greater than expected for their age and other health status. Discharge against medical advice (AMA) is common in this population, and […]
Abstract Number: 216
SHM Converge 2024
Background: Project Caring for Patients with Opioid Misuse through Evidence-Based Treatment (COMET) launched in 2019 to provide patients with opioid use disorders (OUD) individualized and evidence-based care at Duke University Hospital (DUH). Patients with OUD have higher rates of self-directed discharge (SDD) which is associated with higher healthcare utilization costs, hospital readmissions, and adverse health […]
Abstract Number: 224
SHM Converge 2021
Background: Biases related to people with substance use disorder (SUD) actually increase during time spent in formal medical education, and continue into practice. Leading health professional education groups across medicine, nursing, pharmacy, and social work, including the Association of American Medical Colleges (AAMC), have recognized addressing substance use disorders including stigma and bias as a […]
Abstract Number: 229
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Driven by the current opioid epidemic, drug overdose has become the leading cause of unintentional death nationwide. Efforts are underway to decrease unnecessary opioid prescribing. Hospitalists care for many patients with preexisting opioid prescriptions or appropriately prescribed new opioids at discharge. Though naloxone decreases the morbidity and mortality associated with opioid overdose, most patients […]
Abstract Number: 242
SHM Converge 2021
Background: Opioid overdose in the United States continues to rise. Naloxone is an opioid antagonist that is FDA-approved for reversing opioid overdose. Current CDC guidelines recommend prescribing naloxone to patients at high risk of opioid overdose, including patients with concurrent benzodiazepine use, a prior history of overdose, and those receiving high doses of opioids (>50 […]
Abstract Number: 255
Hospital Medicine 2020, Virtual Competition
Background: Inpatient addiction consultant services are an innovative and proliferating tool used to confront the opioid epidemic. As healthcare systems seek to address gaps in care for patients with substance use disorder (SUD), the inpatient setting is increasingly understood as a unique opportunity for counseling, referral for treatment, and initiation of medication assistance treatment (MAT) […]
Abstract Number: 275
SHM Converge 2023
Background: In 2021 there were over 80,000 opioid overdose deaths. Studies show that inpatient hospitalizations are a vital moment in treating patients with opioid use disorder (OUD). Initiation of opioid agonist therapy (OAT: buprenorphine or methadone) is associated with a profound mortality benefit, with some studies suggesting a number needed to treat of less than […]
Abstract Number: 293
SHM Converge 2021
Background: Opioid use disorder (OUD) is a chronic relapsing disease that has become an epidemic in the United States. Overdoses of prescription and illicit opioids have killed almost 450,000 Americans between 1999-2018 (1). Guidelines on OUD management recommend, in combination with behavioral therapy, opioid agonist therapy as the first-line treatment option with antagonist therapy as an alternative option. OUD-related inpatient admissions represent […]
Abstract Number: 301
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Persons with opioid use disorder (OUD) represent an estimated 4-11% of hospitalized patients and are increasingly admitted for opioid-related complications. In response to the opioid epidemic, national organizations have recommended hospitals develop protocols to engage patients with OUD in opioid agonist treatment (OAT) during hospitalization. Buprenorphine is an effective OAT for OUD that is […]